Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-04-08
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-08 (study day 62.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate BLISTER — outcome: RECOVERED/RESOLVED; onset 2013-06-08 (study day 62.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-22 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-04-22 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-22 (study day 15.0); relationship: PROBABLE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-04-22 (study day 15.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.